Aspire Pharmaceuticals, Inc.
FDA-inspected organization
Aspire Pharmaceuticals, Inc. has been audited by the FDA 15 times between 2000 and 2023 across all 2 sites.
Documents
FDA 483 Aspire Pharmaceuticals, Inc., Somerset | 2014
Out of stock
FDA 483 Aspire Pharmaceuticals, Inc., Somerset | 2010
Out of stock
FDA 483 Aspire Pharmaceuticals, Inc., Somerset | 2006
Out of stock
FDA 483 Aspire Pharmaceuticals, Inc., Somerset | 2006
Out of stock
FDA 483 Aspire Pharmaceuticals, Inc., Somerset | 2005
Out of stock
FDA 483 Aspire Pharmaceuticals, Inc., Somerset | 2003
Out of stock
FDA 483 Aspire Pharmaceuticals, Inc., Somerset | 2002
Out of stock
FDA Investigators (19)
- Robin P. Mathew, FDA Investigator
- Charlotte P. Chang, FDA Investigator
- Annet R. Rajan, FDA Investigator
- Jessica M. Monteiro, FDA Investigator
- Lata C. Mathew, FDA Investigator
- Justin A. Boyd, FDA Investigator
- Karen A. Spencer, FDA Investigator
- Dhaval H. Patel, FDA Investigator
- Raymond L. Cheung, FDA Investigator
- Doreen P. Gubbay, FDA Investigator
- Justine Tomasso, FDA Investigator
- Regina T. Brown, FDA Investigator
- Annemarie Bodnar, FDA Investigator
- Antoinette L. Ravelli, FDA Investigator
- Kelli F. Dobilas, FDA Investigator
- Amy L. Singer, FDA Investigator
- Paul L. Bellamy, FDA Investigator
- Kristy A. Zielny, FDA Investigator
- Cntrctmntr Mielziner, FDA Investigator